Alnylam Pharmaceuticals, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Alnylam Pharmaceuticals, Inc. Website Screenshot

http://www.alnylam.com

Alnylam Pharmaceuticals, Inc. Company Intro

Learn about Alnylam Pharmaceuticals, RNAi therapeutics, and the company's efforts in treating amyloidosis, hyperoxaluria, and porphyria.

Industry

Healthcare

Alnylam Pharmaceuticals, Inc. Headquaters

675 West Kendall Street
Cambridge,02142
United States


Alnylam Pharmaceuticals, Inc. Share price

27 Oct 2020 01:04 GMT

$130.08

-1.76 (-1.33 %)


Alnylam Pharmaceuticals, Inc. Market cap

$14.922 B


WMC RANKING

2020

Alnylam Pharmaceuticals, Inc. # 282

Biotechnology



Latest Alnylam Pharmaceuticals, Inc. News

News 26 Oct 2020

Trevena (TRVN) to Report Q3 Earnings: What's in the Cards?

Alnylam ALNY has an Earnings ESP of +4.23% and a Zacks Rank #3. Alexion Pharmaceuticals Inc. ALXN has an Earnings ESP of +0.84% and a Zacks Rank of ...

News 26 Oct 2020

Genprex promotes Eric Chapdelaine to VP of manufacturing

Genprex Inc (NASDAQ:GNPX), a clinical-stage gene therapy company ... as quality control manager of specifications at Alnylam Pharmaceuticals, where he led ...

News 26 Oct 2020

Hemoglobinopathies Drugs Market | Growing Trade Among Emerging Economies Opening New Opportunities (2020-2026)

Gamida Cell Alnylam Pharmaceuticals Biogen Idec Sangamo BioSciences Inc. Genetix Pharmaceuticals/Bluebird Bio Global Blood Therapeutics Inc. Pfizer Inc.

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Alnylam Pharmaceuticals, Inc. 6.23 21.65 16.35 0 0 0 28.44
Alexion Pharmaceuticals, Inc. 100 13.29 100 20 0 0 100
Vertex Pharmaceuticals Incorporated 97.58 100 4.09 26 0 0 97.35
3SBio Inc. 96.05 0 0 4 0 0 2.78
Incyte Corporation 40.27 14.26 7.21 100 0 0 90.91

Alnylam Pharmaceuticals, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Alnylam Pharmaceuticals, Inc. $345,180 $1,217,949 $-846,170 $14.922B 282
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $26.467B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $53.956B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.394B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.779B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Alnylam Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors



Alnylam Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors


Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries